67 related articles for article (PubMed ID: 27149377)
21. RalGDS family members couple Ras to Ral signalling and that's not all.
Ferro E; Trabalzini L
Cell Signal; 2010 Dec; 22(12):1804-10. PubMed ID: 20478380
[TBL] [Abstract][Full Text] [Related]
22. The RAL signaling network: Cancer and beyond.
Apken LH; Oeckinghaus A
Int Rev Cell Mol Biol; 2021; 361():21-105. PubMed ID: 34074494
[TBL] [Abstract][Full Text] [Related]
23. RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
O Santos A; Parrini MC; Camonis J
PLoS One; 2016; 11(5):e0154840. PubMed ID: 27149377
[TBL] [Abstract][Full Text] [Related]
24. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
D'Aloia A; Berruti G; Costa B; Schiller C; Ambrosini R; Pastori V; Martegani E; Ceriani M
Exp Cell Res; 2018 Jan; 362(2):349-361. PubMed ID: 29208460
[TBL] [Abstract][Full Text] [Related]
25. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
Xu X; Jiang J; Yao L; Ji B
Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
[TBL] [Abstract][Full Text] [Related]
26. Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation.
Bum-Erdene K; Ghozayel MK; Xu D; Meroueh SO
ChemMedChem; 2022 Mar; 17(6):e202100750. PubMed ID: 35061330
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 interacts and collaborates with Ral GTPases enhancing cell detachment and motility.
Fernández RM; Ruiz-Miró M; Dolcet X; Aldea M; Garí E
Oncogene; 2011 Apr; 30(16):1936-46. PubMed ID: 21242975
[TBL] [Abstract][Full Text] [Related]
28. Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.
Gentry LR; Martin TD; Reiner DJ; Der CJ
Biochim Biophys Acta; 2014 Dec; 1843(12):2976-2988. PubMed ID: 25219551
[TBL] [Abstract][Full Text] [Related]
29. An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.
Seguin L; Kato S; Franovic A; Camargo MF; Lesperance J; Elliott KC; Yebra M; Mielgo A; Lowy AM; Husain H; Cascone T; Diao L; Wang J; Wistuba II; Heymach JV; Lippman SM; Desgrosellier JS; Anand S; Weis SM; Cheresh DA
Nat Cell Biol; 2014 May; 16(5):457-68. PubMed ID: 24747441
[TBL] [Abstract][Full Text] [Related]
30. Acquisition of epithelial-mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells.
Yang Q; Huang J; Wu Q; Cai Y; Zhu L; Lu X; Chen S; Chen C; Wang Z
Br J Cancer; 2014 Apr; 110(8):1958-67. PubMed ID: 24642627
[TBL] [Abstract][Full Text] [Related]
31. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
[TBL] [Abstract][Full Text] [Related]
32. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
[TBL] [Abstract][Full Text] [Related]
33. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
[TBL] [Abstract][Full Text] [Related]
34. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors.
Starostina NG; Kipreos ET
Trends Cell Biol; 2012 Jan; 22(1):33-41. PubMed ID: 22154077
[TBL] [Abstract][Full Text] [Related]
35. The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.
Neel NF; Martin TD; Stratford JK; Zand TP; Reiner DJ; Der CJ
Genes Cancer; 2011 Mar; 2(3):275-87. PubMed ID: 21779498
[TBL] [Abstract][Full Text] [Related]
36. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanisms.
Vigil D; Martin TD; Williams F; Yeh JJ; Campbell SL; Der CJ
J Biol Chem; 2010 Nov; 285(45):34729-40. PubMed ID: 20801877
[TBL] [Abstract][Full Text] [Related]
37. The PH-PxxP domain of RalGPS2 promotes PC12 cells differentiation acting as a dominant negative for RalA GTPase activation.
Ceriani M; Amigoni L; Scandiuzzi C; Berruti G; Martegani E
Neurosci Res; 2010 Mar; 66(3):290-8. PubMed ID: 20025911
[TBL] [Abstract][Full Text] [Related]
38. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells.
Hung WC; Tseng WL; Shiea J; Chang HC
Cancer Lett; 2010 Feb; 288(2):156-61. PubMed ID: 19625121
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.
Cascone I; Selimoglu R; Ozdemir C; Del Nery E; Yeaman C; White M; Camonis J
EMBO J; 2008 Sep; 27(18):2375-87. PubMed ID: 18756269
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
